Search Results - "Zblewski, Darci L"
-
1
A Pilot Study of the Telomerase Inhibitor Imetelstat for Myelofibrosis
Published in The New England journal of medicine (03-09-2015)“…Imetelstat, a telomerase inhibitor, induced complete or partial responses in 21% of patients with refractory myelofibrosis. In some patients, reversal of…”
Get full text
Journal Article -
2
ASXL1 and CBL mutations are independently predictive of inferior survival in advanced systemic mastocytosis
Published in British journal of haematology (01-11-2016)Get full text
Journal Article -
3
Mayo Clinic experience with 1123 adults with acute myeloid leukemia
Published in Blood cancer journal (New York) (02-03-2021)“…Between 2004 and 2017, a total of 1123 adult patients (median age 65 years; 61% males) with newly diagnosed acute myeloid leukemia (AML), not including acute…”
Get full text
Journal Article -
4
Mayo Clinic Hematology Fellowship for Advanced Practice Providers
Published in Journal of the advanced practitioner in oncology (01-05-2020)“…Advanced practice providers (APPs), including nurse practitioners (NPs) and physician assistants (PAs), are part of a growing cancer care workforce. Current…”
Get full text
Journal Article -
5
Phase 1b Study of IGF-Methotrexate Conjugate in the Treatment of High-grade Myelodysplastic Syndromes
Published in Anticancer research (01-07-2020)“…Background/Aim: The insulin-like growth factor type 1 receptor (IGF-1R) is overexpressed in myelodysplastic syndrome (MDS) cells, and 765IGF-Methotrexate…”
Get full text
Journal Article -
6
A population‐based study of chronic eosinophilic leukemia‐not otherwise specified in the United States
Published in American journal of hematology (01-10-2020)Get full text
Journal Article -
7
Mayo Alliance Prognostic Model for Myelodysplastic Syndromes: Integration of Genetic and Clinical Information
Published in Mayo Clinic proceedings (01-10-2018)“…To develop a new risk model for primary myelodysplastic syndromes (MDS) that integrates information on mutations, karyotype, and clinical variables. Patients…”
Get full text
Journal Article -
8
Frequency of venous thrombotic events in patients with myelodysplastic syndrome and 5q deletion syndrome during lenalidomide therapy
Published in Annals of hematology (01-02-2019)“…Lenalidomide is known to increase the risk of venous thromboembolism in patients with hematologic malignancies. The role of antithrombotic prophylaxis in…”
Get full text
Journal Article -
9
-
10
A population-based study of chronic neutrophilic leukemia in the United States
Published in Blood cancer journal (New York) (15-06-2020)Get full text
Journal Article